J Korean Oncol Nurs.  2010 Aug;10(2):231-239.

Characteristics and Quality of Life in Patients with Chemotherapy-Induced Peripheral Neuropathy

Affiliations
  • 1Department of Nursing, Samsung Medical Center, Seoul, Korea. mikyong.kawk@samsung.com
  • 2Department of Clinical Nursing Science, Sunkyunkwan University School of Medicine, Seoul, Korea.

Abstract

PURPOSE
The purpose of study was to identify how patients experienced chemotherapy-induced peripheral neuropathy (CIPN) and quality of life related to CIPN.
METHODS
This was a descriptive research. We collected data from 105 patients with chemotherapy-induced peripheral neuropathy. They completed a self-reported questionnaire including Eastern Cooperative Oncology Group (EORTC) CIPN20 and items related to their disease and peripheral neuropathy. The investigators filled in part of items about disease and treatment.
RESULTS
In the study, duration of peripheral neuropathy was 9.4 month and 54.3% of patients used pharmacological or non-pharmacological interventions. Patients reported the highest score for sensory scale and it's score was 38.74+/-20.24. The scores for motor scale and autonomic scale were 21.95+/-19.19 and 26.61+/-21.0 respectively. This showed that patients more suffered from sensory neuropathy than any other domain of neuropathy. The most frequently selected two items were 'did you have tingling fingers or hands?' and 'did you have tingling toes or feet?'.
CONCLUSION
The results of this study will provide useful information for chemotherapy-induced peripheral neuropathy.

Keyword

Chemotherapy; Peripheral neuropathy; Quality of life

MeSH Terms

Fingers
Humans
Peripheral Nervous System Diseases
Quality of Life
Surveys and Questionnaires
Research Personnel
Toes
Full Text Links
  • JKON
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error